Yearly Archives - 2020

Skin-care product based on U of T Engineering research donated to health-care workers fighting COVID-19

A U of T Engineering spinoff company has donated its entire stock of skin-care product to health-care workers fighting the global pandemic. Several years ago, Professor Milica Radisic (BME, ChemE) and her team developed a peptide-hydrogel biomaterial that prompts skin cells to “crawl” toward one another. The material was initially designed to help close the chronic, non-healing wounds often associated with diabetes, such as bed sores and foot ulcers. Shortly thereafter, the technology was spun out into Quthero, Inc. a...
Read more...

Major League Baseball Teams Stand by ZetrOZ’s SAM 2.0 Ability to Help Athletes Recover From Muscle Injury Without Surgery

SAM 2.0, an FDA-cleared 2020 bio regenerative medical device that helps reduce pain associated with tendon, ligament, and muscle injuries has received positive feedback from athletes at nearly every skill level for its ability to penetrate deep into the tissue. Most notably, athletic staff from a number of professional major league baseball teams have shared their positive experiences with Sustained Acoustic Medicine-SAM, and its ability to accelerate the natural healing process without the need for surgery.
Read more...

Corbus Pharmaceuticals Announces Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis Did Not Meet Primary Endpoint

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced topline results from its 28-week Phase 2b study of lenabasum in patients with cystic fibrosis (CF). The study enrolled patients in the U.S., Canada and Europe at high risk for recurrent pulmonary exacerbations (PEx). Subjects received lenabasum or placebo added to their background treatments for CF. Read more >>
Read more...

Elite Athletes Use ZetrOZ Systems’ sam® Technology to Heal Quicker and Avoid Surgery

sam® ultrasound, ZetrOZ Systems' sustained acoustic medicine device, is the preferred healing solution of countless professional and collegiate athletes. The wearable, long-duration ultrasound technology helps athletes avoid surgery while accelerating natural healing, proving to be extremely valuable in cases of acute and chronic pain, especially those that involve soft tissue damage. Read more >>
Read more...

Oncocyte Agrees to Enter Licensing and Collaboration Agreement with Chronix Biomedical

Oncocyte Corporation, a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it has agreed to enter a licensing and collaboration agreement with Chronix Biomedical. Oncocyte is licensing Chronix’s patented CNI Monitor technology for the TheraSure™-CNI MONITOR clinical assay. Read more >>
Read more...